Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Fig1)
Carvedilol Tablet, Film Coated
Product Images NDC 71335-0273
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 71335-0273). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Fig2)
This is a figure from COPERNICUS that shows the effects on mortality for different subgroups. The subgroups are divided based on gender, age, race, diabetes status, ischemic status, heart failure status, heart rate, blood pressure, and whether or not they received spironolactone treatment. The hazard ratio is shown on the y-axis and ranges from 0 to 20. No further information can be extracted from this text.*
Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Fig3)
Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Fig4)
Chemical Structure (Carvedilol Str)
Label (Lbl713350273)
This appears to be a medication label for a prescription of Carvedilol 25mg tablets. The label provides instructions in regards to proper storage, including keeping the medication at room temperature and out of reach of children. It also includes information on its manufacturer, Buyant Ranch Prcpach Bunbank, and an identification number, NDC 7133502731 040701001523487.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
